

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.63902262 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.54505159 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.48511419 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.48511419 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.82787412 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 4.82787412 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.82787412 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 4.82787412 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.82787412 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.82787412 |
| 11 | detection of molecule of bacterial origin (GO:0032490) | 4.79560848 |
| 12 | negative regulation of interleukin-12 production (GO:0032695) | 4.74248789 |
| 13 | detection of biotic stimulus (GO:0009595) | 4.39255336 |
| 14 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.37759245 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.37442936 |
| 16 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.32766716 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.25022786 |
| 18 | cellular extravasation (GO:0045123) | 4.24702504 |
| 19 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.23290834 |
| 20 | response to peptidoglycan (GO:0032494) | 4.08368309 |
| 21 | respiratory burst (GO:0045730) | 4.06536225 |
| 22 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.01872564 |
| 23 | macrophage activation (GO:0042116) | 3.97460523 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 3.96521140 |
| 25 | myeloid cell activation involved in immune response (GO:0002275) | 3.88507455 |
| 26 | immunoglobulin mediated immune response (GO:0016064) | 3.84104211 |
| 27 | neutrophil activation involved in immune response (GO:0002283) | 3.80397008 |
| 28 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.79319204 |
| 29 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.78589940 |
| 30 | neutrophil mediated immunity (GO:0002446) | 3.70884091 |
| 31 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.67877128 |
| 32 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.67877128 |
| 33 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.66209662 |
| 34 | indolalkylamine catabolic process (GO:0046218) | 3.61607154 |
| 35 | tryptophan catabolic process (GO:0006569) | 3.61607154 |
| 36 | indole-containing compound catabolic process (GO:0042436) | 3.61607154 |
| 37 | response to host immune response (GO:0052572) | 3.61399044 |
| 38 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.61399044 |
| 39 | leukocyte aggregation (GO:0070486) | 3.60574772 |
| 40 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.53204693 |
| 41 | positive regulation of antigen processing and presentation (GO:0002579) | 3.46950222 |
| 42 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.46207315 |
| 43 | response to muramyl dipeptide (GO:0032495) | 3.45649846 |
| 44 | detection of bacterium (GO:0016045) | 3.43727535 |
| 45 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.42746521 |
| 46 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.41944200 |
| 47 | cellular response to exogenous dsRNA (GO:0071360) | 3.40999146 |
| 48 | kynurenine metabolic process (GO:0070189) | 3.38273985 |
| 49 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.37946509 |
| 50 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.37493591 |
| 51 | negative regulation of T cell mediated immunity (GO:0002710) | 3.36353523 |
| 52 | detection of other organism (GO:0098543) | 3.35810896 |
| 53 | microglial cell activation (GO:0001774) | 3.32340344 |
| 54 | macrophage activation involved in immune response (GO:0002281) | 3.30402124 |
| 55 | regulation of triglyceride catabolic process (GO:0010896) | 3.30114398 |
| 56 | pinocytosis (GO:0006907) | 3.29660074 |
| 57 | aromatic amino acid family catabolic process (GO:0009074) | 3.29182379 |
| 58 | complement activation, alternative pathway (GO:0006957) | 3.28852080 |
| 59 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.28571051 |
| 60 | positive regulation of mast cell activation (GO:0033005) | 3.27462682 |
| 61 | regulation of tolerance induction (GO:0002643) | 3.26489025 |
| 62 | regulation of phospholipase A2 activity (GO:0032429) | 3.25752034 |
| 63 | tryptophan metabolic process (GO:0006568) | 3.25545519 |
| 64 | alpha-linolenic acid metabolic process (GO:0036109) | 3.24976688 |
| 65 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.23814885 |
| 66 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.23735794 |
| 67 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.21846769 |
| 68 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.20741973 |
| 69 | response to host (GO:0075136) | 3.20741973 |
| 70 | response to host defenses (GO:0052200) | 3.20741973 |
| 71 | positive regulation of interferon-alpha production (GO:0032727) | 3.19343458 |
| 72 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.19224138 |
| 73 | regulation of regulated secretory pathway (GO:1903305) | 3.19019232 |
| 74 | urea metabolic process (GO:0019627) | 3.18494603 |
| 75 | urea cycle (GO:0000050) | 3.18494603 |
| 76 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.17532655 |
| 77 | myeloid leukocyte mediated immunity (GO:0002444) | 3.16287899 |
| 78 | leukocyte degranulation (GO:0043299) | 3.16270478 |
| 79 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.14859140 |
| 80 | low-density lipoprotein particle clearance (GO:0034383) | 3.13304198 |
| 81 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.12925559 |
| 82 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.11410111 |
| 83 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.10986201 |
| 84 | killing of cells of other organism (GO:0031640) | 3.10778844 |
| 85 | disruption of cells of other organism (GO:0044364) | 3.10778844 |
| 86 | plasma lipoprotein particle clearance (GO:0034381) | 3.10403237 |
| 87 | regulation of T cell tolerance induction (GO:0002664) | 3.09460286 |
| 88 | intracellular pH reduction (GO:0051452) | 3.08186667 |
| 89 | phospholipid efflux (GO:0033700) | 3.06707137 |
| 90 | defense response to protozoan (GO:0042832) | 3.05783337 |
| 91 | neutrophil chemotaxis (GO:0030593) | 3.05316341 |
| 92 | positive regulation of leukocyte degranulation (GO:0043302) | 3.04061417 |
| 93 | neutrophil activation (GO:0042119) | 3.03948242 |
| 94 | type I interferon signaling pathway (GO:0060337) | 3.03766328 |
| 95 | cellular response to type I interferon (GO:0071357) | 3.03766328 |
| 96 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.02545114 |
| 97 | myeloid leukocyte activation (GO:0002274) | 3.01735923 |
| 98 | germinal center formation (GO:0002467) | 3.01612572 |
| 99 | defense response to fungus (GO:0050832) | 3.01109943 |
| 100 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.01062709 |
| 101 | response to type I interferon (GO:0034340) | 3.00019898 |
| 102 | negative regulation of interleukin-6 production (GO:0032715) | 2.99245019 |
| 103 | regulation of interferon-alpha production (GO:0032647) | 2.98107927 |
| 104 | neutrophil migration (GO:1990266) | 2.97598753 |
| 105 | granulocyte activation (GO:0036230) | 2.96096122 |
| 106 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.94304878 |
| 107 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.93608069 |
| 108 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.93608069 |
| 109 | positive regulation of regulated secretory pathway (GO:1903307) | 2.92978824 |
| 110 | B cell receptor signaling pathway (GO:0050853) | 2.91981303 |
| 111 | regulation of antigen processing and presentation (GO:0002577) | 2.91762680 |
| 112 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.90803083 |
| 113 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.90102657 |
| 114 | positive regulation of mast cell degranulation (GO:0043306) | 2.89980116 |
| 115 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.89980116 |
| 116 | regulation of mast cell activation (GO:0033003) | 2.89392902 |
| 117 | nitrogen cycle metabolic process (GO:0071941) | 2.88756315 |
| 118 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.88335443 |
| 119 | positive regulation of lipid catabolic process (GO:0050996) | 2.88222824 |
| 120 | L-phenylalanine catabolic process (GO:0006559) | 2.88062003 |
| 121 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.88062003 |
| 122 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.87560423 |
| 123 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.86431598 |
| 124 | positive regulation of B cell differentiation (GO:0045579) | 2.85656229 |
| 125 | cell killing (GO:0001906) | 2.81446607 |
| 126 | high-density lipoprotein particle remodeling (GO:0034375) | 2.81115564 |
| 127 | response to interleukin-15 (GO:0070672) | 2.80657453 |
| 128 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.79348548 |
| 129 | detection of external biotic stimulus (GO:0098581) | 2.78333694 |
| 130 | regulation of cholesterol storage (GO:0010885) | 2.78177507 |
| 131 | reactive oxygen species biosynthetic process (GO:1903409) | 2.78112278 |
| 132 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.77907729 |
| 133 | regulation of B cell differentiation (GO:0045577) | 2.76129326 |
| 134 | regulation of mast cell degranulation (GO:0043304) | 2.74427285 |
| 135 | regulation of monocyte chemotaxis (GO:0090025) | 2.73576229 |
| 136 | protein carboxylation (GO:0018214) | 2.73278417 |
| 137 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.73278417 |
| 138 | B cell mediated immunity (GO:0019724) | 2.72699210 |
| 139 | superoxide anion generation (GO:0042554) | 2.70826916 |
| 140 | regulation of cholesterol esterification (GO:0010872) | 2.70488011 |
| 141 | regulation of protein activation cascade (GO:2000257) | 2.69920248 |
| 142 | L-phenylalanine metabolic process (GO:0006558) | 2.69496131 |
| 143 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.69496131 |
| 144 | bile acid biosynthetic process (GO:0006699) | 2.66303751 |
| 145 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.66099649 |
| 146 | leukocyte mediated cytotoxicity (GO:0001909) | 2.66026848 |
| 147 | negative regulation of mast cell activation (GO:0033004) | 2.64822617 |
| 148 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.62547625 |
| 149 | regulation of leukocyte degranulation (GO:0043300) | 2.60009113 |
| 150 | phospholipid homeostasis (GO:0055091) | 2.59701772 |
| 151 | response to fungus (GO:0009620) | 2.59289232 |
| 152 | regulation of complement activation (GO:0030449) | 2.57087261 |
| 153 | amino-acid betaine metabolic process (GO:0006577) | 2.57014800 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.39023429 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.34140096 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.29009285 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.00571839 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.97212862 |
| 6 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.71029196 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.57545445 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.43978114 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.36280788 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.22304449 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.20884231 |
| 12 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.02852341 |
| 13 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.70217860 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.68143052 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.63585590 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.62041735 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.60686711 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.53115298 |
| 19 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.36424149 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.32271312 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.30650508 |
| 22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.27513252 |
| 23 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.27258165 |
| 24 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.27132379 |
| 25 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.26072693 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.22883401 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.14209129 |
| 28 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.12118648 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.07463925 |
| 30 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.04612065 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.90678514 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83613454 |
| 33 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.79926718 |
| 34 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.77401823 |
| 35 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.68056340 |
| 36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.67483501 |
| 37 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.65701558 |
| 38 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.62235049 |
| 39 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.62164970 |
| 40 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.60301255 |
| 41 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.57790915 |
| 42 | MYC_22102868_ChIP-Seq_BL_Human | 1.57526838 |
| 43 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.52440931 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.44679625 |
| 45 | MAF_26560356_Chip-Seq_TH1_Human | 1.44109467 |
| 46 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.43659907 |
| 47 | MYB_26560356_Chip-Seq_TH2_Human | 1.43219074 |
| 48 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.40332287 |
| 49 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.39710609 |
| 50 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.38822182 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.38373531 |
| 52 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.37262657 |
| 53 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.35240270 |
| 54 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.34823536 |
| 55 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33713184 |
| 56 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.33026874 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32637350 |
| 58 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31966577 |
| 59 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.31363370 |
| 60 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.27363579 |
| 61 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.22464147 |
| 62 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20942509 |
| 63 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20678264 |
| 64 | MYB_26560356_Chip-Seq_TH1_Human | 1.20120607 |
| 65 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.19626074 |
| 66 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.19550853 |
| 67 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19034823 |
| 68 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.18481285 |
| 69 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18267286 |
| 70 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17577167 |
| 71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15864683 |
| 72 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.15402898 |
| 73 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14986134 |
| 74 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11745499 |
| 75 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.11741499 |
| 76 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.09886244 |
| 77 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.09849610 |
| 78 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09668298 |
| 79 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09248850 |
| 80 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08801731 |
| 81 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08391151 |
| 82 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05739947 |
| 83 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05048459 |
| 84 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.03556279 |
| 85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03149285 |
| 86 | GATA3_26560356_Chip-Seq_TH2_Human | 1.02728486 |
| 87 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02598738 |
| 88 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02513238 |
| 89 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.02395684 |
| 90 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01306869 |
| 91 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00419549 |
| 92 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99774427 |
| 93 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99171591 |
| 94 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98770574 |
| 95 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98631519 |
| 96 | UTX_26944678_Chip-Seq_JUKART_Human | 0.97952762 |
| 97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97349978 |
| 98 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.95897903 |
| 99 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.95571791 |
| 100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.93285270 |
| 101 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.91788997 |
| 102 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91521257 |
| 103 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.90306558 |
| 104 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90023175 |
| 105 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.89663568 |
| 106 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89331377 |
| 107 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.89257652 |
| 108 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.87154730 |
| 109 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.86984561 |
| 110 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.86885908 |
| 111 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.86621758 |
| 112 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.86358973 |
| 113 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83696231 |
| 114 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81481218 |
| 115 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80920842 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.79980186 |
| 117 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.78391190 |
| 118 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.77955654 |
| 119 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.77328431 |
| 120 | MAF_26560356_Chip-Seq_TH2_Human | 0.76572522 |
| 121 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75023180 |
| 122 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.74733262 |
| 123 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.74429359 |
| 124 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.73986457 |
| 125 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73820454 |
| 126 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.72971708 |
| 127 | P300_27268052_Chip-Seq_Bcells_Human | 0.72054485 |
| 128 | GATA1_19941826_ChIP-Seq_K562_Human | 0.69935062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.67070502 |
| 2 | MP0003436_decreased_susceptibility_to | 3.34094305 |
| 3 | MP0005360_urolithiasis | 3.27208133 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.14448698 |
| 5 | MP0003303_peritoneal_inflammation | 2.75996825 |
| 6 | MP0009785_altered_susceptibility_to | 2.73396974 |
| 7 | MP0001853_heart_inflammation | 2.66707669 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 2.63009639 |
| 9 | MP0002419_abnormal_innate_immunity | 2.53219873 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.46341701 |
| 11 | MP0005365_abnormal_bile_salt | 2.33854909 |
| 12 | MP0005025_abnormal_response_to | 2.33745431 |
| 13 | MP0000685_abnormal_immune_system | 2.30240623 |
| 14 | MP0009840_abnormal_foam_cell | 2.27790164 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.14062914 |
| 16 | MP0005387_immune_system_phenotype | 2.10787034 |
| 17 | MP0001790_abnormal_immune_system | 2.10787034 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.10699172 |
| 19 | MP0003172_abnormal_lysosome_physiology | 2.05555968 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.04389557 |
| 21 | MP0004510_myositis | 2.01064348 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.00395279 |
| 23 | MP0009764_decreased_sensitivity_to | 1.99164504 |
| 24 | MP0002452_abnormal_antigen_presenting | 1.99086861 |
| 25 | MP0010329_abnormal_lipoprotein_level | 1.96165727 |
| 26 | MP0003724_increased_susceptibility_to | 1.94243514 |
| 27 | MP0001800_abnormal_humoral_immune | 1.94033563 |
| 28 | MP0005451_abnormal_body_composition | 1.93141340 |
| 29 | MP0006082_CNS_inflammation | 1.92004613 |
| 30 | MP0005671_abnormal_response_to | 1.91554319 |
| 31 | MP0008875_abnormal_xenobiotic_pharmacok | 1.91244985 |
| 32 | MP0002723_abnormal_immune_serum | 1.70090094 |
| 33 | MP0003252_abnormal_bile_duct | 1.67191910 |
| 34 | MP0001819_abnormal_immune_cell | 1.64777348 |
| 35 | MP0002132_abnormal_respiratory_system | 1.63973445 |
| 36 | MP0004947_skin_inflammation | 1.60554201 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.60140382 |
| 38 | MP0002420_abnormal_adaptive_immunity | 1.58279854 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.57000938 |
| 40 | MP0002796_impaired_skin_barrier | 1.52311774 |
| 41 | MP0003763_abnormal_thymus_physiology | 1.52103829 |
| 42 | MP0001666_abnormal_nutrient_absorption | 1.51927033 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.48740375 |
| 44 | MP0002405_respiratory_system_inflammati | 1.48305483 |
| 45 | MP0000343_altered_response_to | 1.47484029 |
| 46 | MP0008469_abnormal_protein_level | 1.45590514 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.45510695 |
| 48 | MP0002166_altered_tumor_susceptibility | 1.43349406 |
| 49 | MP0002254_reproductive_system_inflammat | 1.43013959 |
| 50 | MP0000609_abnormal_liver_physiology | 1.42873705 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.42053262 |
| 52 | MP0009278_abnormal_bone_marrow | 1.39023907 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.38518196 |
| 54 | MP0003453_abnormal_keratinocyte_physiol | 1.37261063 |
| 55 | MP0004019_abnormal_vitamin_homeostasis | 1.37213585 |
| 56 | MP0002722_abnormal_immune_system | 1.36134361 |
| 57 | MP0002006_tumorigenesis | 1.31618627 |
| 58 | MP0003075_altered_response_to | 1.29534089 |
| 59 | MP0008004_abnormal_stomach_pH | 1.24532140 |
| 60 | MP0003690_abnormal_glial_cell | 1.23792326 |
| 61 | MP0002837_dystrophic_cardiac_calcinosis | 1.21363123 |
| 62 | MP0002118_abnormal_lipid_homeostasis | 1.21255469 |
| 63 | MP0010234_abnormal_vibrissa_follicle | 1.19272231 |
| 64 | MP0005319_abnormal_enzyme/_coenzyme | 1.18057237 |
| 65 | MP0005164_abnormal_response_to | 1.16550616 |
| 66 | MP0005058_abnormal_lysosome_morphology | 1.14213669 |
| 67 | MP0002876_abnormal_thyroid_physiology | 1.13186763 |
| 68 | MP0005332_abnormal_amino_acid | 1.12470413 |
| 69 | MP0003300_gastrointestinal_ulcer | 1.11104569 |
| 70 | MP0001764_abnormal_homeostasis | 1.10661313 |
| 71 | MP0005167_abnormal_blood-brain_barrier | 1.10353446 |
| 72 | MP0002277_abnormal_respiratory_mucosa | 1.10205010 |
| 73 | MP0005670_abnormal_white_adipose | 1.10137368 |
| 74 | MP0005397_hematopoietic_system_phenotyp | 1.10003407 |
| 75 | MP0001545_abnormal_hematopoietic_system | 1.10003407 |
| 76 | MP0003828_pulmonary_edema | 1.09179089 |
| 77 | MP0000716_abnormal_immune_system | 1.07358966 |
| 78 | MP0001216_abnormal_epidermal_layer | 1.05620461 |
| 79 | MP0009763_increased_sensitivity_to | 1.05069509 |
| 80 | MP0000703_abnormal_thymus_morphology | 1.03244070 |
| 81 | MP0005166_decreased_susceptibility_to | 1.02556694 |
| 82 | MP0009333_abnormal_splenocyte_physiolog | 1.00423156 |
| 83 | MP0003186_abnormal_redox_activity | 1.00232133 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 1.00044306 |
| 85 | MP0003566_abnormal_cell_adhesion | 0.98152173 |
| 86 | MP0000858_altered_metastatic_potential | 0.97615930 |
| 87 | MP0003183_abnormal_peptide_metabolism | 0.97334474 |
| 88 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.95110730 |
| 89 | MP0003705_abnormal_hypodermis_morpholog | 0.92713455 |
| 90 | MP0003448_altered_tumor_morphology | 0.89621493 |
| 91 | MP0010352_gastrointestinal_tract_polyps | 0.89607383 |
| 92 | MP0000604_amyloidosis | 0.89208666 |
| 93 | MP0002396_abnormal_hematopoietic_system | 0.89195262 |
| 94 | MP0002398_abnormal_bone_marrow | 0.89004871 |
| 95 | MP0004782_abnormal_surfactant_physiolog | 0.86928784 |
| 96 | MP0005390_skeleton_phenotype | 0.86288090 |
| 97 | MP0009643_abnormal_urine_homeostasis | 0.86040535 |
| 98 | MP0004381_abnormal_hair_follicle | 0.85963371 |
| 99 | MP0002429_abnormal_blood_cell | 0.85152665 |
| 100 | MP0001663_abnormal_digestive_system | 0.85145101 |
| 101 | MP0005076_abnormal_cell_differentiation | 0.83921325 |
| 102 | MP0000689_abnormal_spleen_morphology | 0.83626326 |
| 103 | MP0004883_abnormal_blood_vessel | 0.83132780 |
| 104 | MP0002060_abnormal_skin_morphology | 0.81187199 |
| 105 | MP0008260_abnormal_autophagy | 0.80068944 |
| 106 | MP0000579_abnormal_nail_morphology | 0.79911027 |
| 107 | MP0001851_eye_inflammation | 0.79317058 |
| 108 | MP0005310_abnormal_salivary_gland | 0.78943561 |
| 109 | MP0003866_abnormal_defecation | 0.78877450 |
| 110 | MP0003638_abnormal_response/metabolism_ | 0.78275602 |
| 111 | MP0005666_abnormal_adipose_tissue | 0.77930878 |
| 112 | MP0000598_abnormal_liver_morphology | 0.76867288 |
| 113 | MP0005334_abnormal_fat_pad | 0.76264467 |
| 114 | MP0003011_delayed_dark_adaptation | 0.75716649 |
| 115 | MP0009765_abnormal_xenobiotic_induced | 0.75513525 |
| 116 | MP0002009_preneoplasia | 0.70390131 |
| 117 | MP0003795_abnormal_bone_structure | 0.70298229 |
| 118 | MP0000490_abnormal_crypts_of | 0.69322332 |
| 119 | MP0005075_abnormal_melanosome_morpholog | 0.67960126 |
| 120 | MP0000249_abnormal_blood_vessel | 0.66959981 |
| 121 | MP0003221_abnormal_cardiomyocyte_apopto | 0.66244399 |
| 122 | MP0004264_abnormal_extraembryonic_tissu | 0.64824463 |
| 123 | MP0000015_abnormal_ear_pigmentation | 0.64742036 |
| 124 | MP0003045_fibrosis | 0.64584955 |
| 125 | MP0004808_abnormal_hematopoietic_stem | 0.63473749 |
| 126 | MP0001873_stomach_inflammation | 0.62935261 |
| 127 | MP0000569_abnormal_digit_pigmentation | 0.60457174 |
| 128 | MP0006054_spinal_hemorrhage | 0.59464960 |
| 129 | MP0005083_abnormal_biliary_tract | 0.59193122 |
| 130 | MP0008874_decreased_physiological_sensi | 0.58431840 |
| 131 | MP0002332_abnormal_exercise_endurance | 0.58320036 |
| 132 | MP0002933_joint_inflammation | 0.55619352 |
| 133 | MP0003091_abnormal_cell_migration | 0.54761090 |
| 134 | MP0005388_respiratory_system_phenotype | 0.53015481 |
| 135 | MP0002133_abnormal_respiratory_system | 0.53015481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.82642487 |
| 2 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.76443442 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.66792919 |
| 4 | Eczematoid dermatitis (HP:0000976) | 5.51077734 |
| 5 | Obstructive lung disease (HP:0006536) | 3.83391372 |
| 6 | Chronic obstructive pulmonary disease (HP:0006510) | 3.83391372 |
| 7 | Abnormality of complement system (HP:0005339) | 3.70336166 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.63121221 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 3.57245442 |
| 10 | Xanthomatosis (HP:0000991) | 3.54758153 |
| 11 | Recurrent skin infections (HP:0001581) | 3.51409543 |
| 12 | Deep venous thrombosis (HP:0002625) | 3.47208075 |
| 13 | Increased cerebral lipofuscin (HP:0011813) | 3.45958383 |
| 14 | Myositis (HP:0100614) | 3.38842436 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.32123819 |
| 16 | Complement deficiency (HP:0004431) | 3.23307857 |
| 17 | Prolonged partial thromboplastin time (HP:0003645) | 3.23226751 |
| 18 | Pustule (HP:0200039) | 3.23153742 |
| 19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.22804994 |
| 20 | Gingivitis (HP:0000230) | 3.22700356 |
| 21 | Joint hemorrhage (HP:0005261) | 3.22609201 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 3.18759076 |
| 23 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.17876218 |
| 24 | Amyloidosis (HP:0011034) | 3.14296149 |
| 25 | Hypochromic microcytic anemia (HP:0004840) | 3.12093751 |
| 26 | Myocardial infarction (HP:0001658) | 3.08937504 |
| 27 | Urticaria (HP:0001025) | 3.02347842 |
| 28 | Intrahepatic cholestasis (HP:0001406) | 2.99849489 |
| 29 | Chest pain (HP:0100749) | 2.96541146 |
| 30 | Episodic fever (HP:0001954) | 2.95315914 |
| 31 | Pulmonary infiltrates (HP:0002113) | 2.95258045 |
| 32 | Gastrointestinal infarctions (HP:0005244) | 2.91242361 |
| 33 | Loss of speech (HP:0002371) | 2.90343403 |
| 34 | Gingival bleeding (HP:0000225) | 2.88889869 |
| 35 | Recurrent fungal infections (HP:0002841) | 2.88770620 |
| 36 | Prolonged bleeding time (HP:0003010) | 2.87925933 |
| 37 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.85520759 |
| 38 | Spontaneous hematomas (HP:0007420) | 2.82035206 |
| 39 | Orchitis (HP:0100796) | 2.80409353 |
| 40 | Nephritis (HP:0000123) | 2.75291972 |
| 41 | Hypobetalipoproteinemia (HP:0003563) | 2.71100274 |
| 42 | Increased IgE level (HP:0003212) | 2.70753813 |
| 43 | Leukocytosis (HP:0001974) | 2.70064103 |
| 44 | Petechiae (HP:0000967) | 2.64934083 |
| 45 | Hyperlipoproteinemia (HP:0010980) | 2.62214572 |
| 46 | T lymphocytopenia (HP:0005403) | 2.62081516 |
| 47 | Hypochromic anemia (HP:0001931) | 2.61463805 |
| 48 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.61274625 |
| 49 | Vasculitis (HP:0002633) | 2.60623813 |
| 50 | Meningitis (HP:0001287) | 2.57416723 |
| 51 | Abnormality of the common coagulation pathway (HP:0010990) | 2.56881626 |
| 52 | Periodontitis (HP:0000704) | 2.56502287 |
| 53 | Glomerulonephritis (HP:0000099) | 2.54696713 |
| 54 | Osteomyelitis (HP:0002754) | 2.54108329 |
| 55 | Abnormality of T cell number (HP:0011839) | 2.51840923 |
| 56 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.48897483 |
| 57 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.48897483 |
| 58 | Abnormality of glycolipid metabolism (HP:0010969) | 2.48897483 |
| 59 | Epidermoid cyst (HP:0200040) | 2.46996423 |
| 60 | Colitis (HP:0002583) | 2.46839061 |
| 61 | Cellulitis (HP:0100658) | 2.46195302 |
| 62 | Hyperglycinuria (HP:0003108) | 2.44138341 |
| 63 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.42347237 |
| 64 | Thick nail (HP:0001805) | 2.39881621 |
| 65 | Disinhibition (HP:0000734) | 2.38557477 |
| 66 | Interstitial pulmonary disease (HP:0006530) | 2.37145895 |
| 67 | Keratoconjunctivitis sicca (HP:0001097) | 2.36549299 |
| 68 | Vacuolated lymphocytes (HP:0001922) | 2.36036086 |
| 69 | Hypolipoproteinemia (HP:0010981) | 2.35904559 |
| 70 | Increased IgM level (HP:0003496) | 2.34742404 |
| 71 | Hypoalphalipoproteinemia (HP:0003233) | 2.34494105 |
| 72 | Increased serum ferritin (HP:0003281) | 2.34227677 |
| 73 | Peritonitis (HP:0002586) | 2.33492985 |
| 74 | Retrobulbar optic neuritis (HP:0100654) | 2.31179703 |
| 75 | Optic neuritis (HP:0100653) | 2.31179703 |
| 76 | Hyperammonemia (HP:0001987) | 2.31126349 |
| 77 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.30382466 |
| 78 | Chronic otitis media (HP:0000389) | 2.29888522 |
| 79 | Stomatitis (HP:0010280) | 2.28840972 |
| 80 | Gastrointestinal inflammation (HP:0004386) | 2.28785609 |
| 81 | Dysostosis multiplex (HP:0000943) | 2.28653081 |
| 82 | Purpura (HP:0000979) | 2.28508080 |
| 83 | Abnormality of the pleura (HP:0002103) | 2.26251915 |
| 84 | Pulmonary embolism (HP:0002204) | 2.24582687 |
| 85 | Hepatosplenomegaly (HP:0001433) | 2.24444742 |
| 86 | Abnormality of iron homeostasis (HP:0011031) | 2.23926920 |
| 87 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.23333635 |
| 88 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.23105686 |
| 89 | Hemoptysis (HP:0002105) | 2.22113705 |
| 90 | Vertigo (HP:0002321) | 2.17825895 |
| 91 | Recurrent viral infections (HP:0004429) | 2.16428092 |
| 92 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.14841245 |
| 93 | Inflammation of the large intestine (HP:0002037) | 2.14320541 |
| 94 | Polycythemia (HP:0001901) | 2.14229295 |
| 95 | Hematochezia (HP:0002573) | 2.14110084 |
| 96 | Abnormality of the peritoneum (HP:0002585) | 2.13377040 |
| 97 | Premature loss of primary teeth (HP:0006323) | 2.13303944 |
| 98 | Abnormality of T cells (HP:0002843) | 2.12464429 |
| 99 | Mitral stenosis (HP:0001718) | 2.12434354 |
| 100 | Microcytic anemia (HP:0001935) | 2.11587954 |
| 101 | Keratoconjunctivitis (HP:0001096) | 2.11190018 |
| 102 | Sepsis (HP:0100806) | 2.10611425 |
| 103 | Hypergammaglobulinemia (HP:0010702) | 2.10506277 |
| 104 | Hypoglycemic coma (HP:0001325) | 2.09096631 |
| 105 | Abnormal platelet volume (HP:0011876) | 2.08671651 |
| 106 | Gangrene (HP:0100758) | 2.08111098 |
| 107 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.07695445 |
| 108 | Recurrent cutaneous fungal infections (HP:0011370) | 2.07695445 |
| 109 | Fat malabsorption (HP:0002630) | 2.07653952 |
| 110 | Granulocytopenia (HP:0001913) | 2.07454484 |
| 111 | Anorexia (HP:0002039) | 2.07223170 |
| 112 | Abnormality of glycine metabolism (HP:0010895) | 2.06699487 |
| 113 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.06699487 |
| 114 | Glomerulopathy (HP:0100820) | 2.06513867 |
| 115 | Polyneuropathy (HP:0001271) | 2.05726835 |
| 116 | Osteolytic defects of the hand bones (HP:0009699) | 2.05576884 |
| 117 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.05576884 |
| 118 | Encephalitis (HP:0002383) | 2.05551779 |
| 119 | Arterial thrombosis (HP:0004420) | 2.05209310 |
| 120 | Malnutrition (HP:0004395) | 2.05194329 |
| 121 | Autoimmune thrombocytopenia (HP:0001973) | 2.04241311 |
| 122 | Amaurosis fugax (HP:0100576) | 2.02910717 |
| 123 | Thrombophlebitis (HP:0004418) | 2.02654181 |
| 124 | Abnormality of the endocardium (HP:0004306) | 2.01894847 |
| 125 | Skin ulcer (HP:0200042) | 2.01710064 |
| 126 | Hyperglycinemia (HP:0002154) | 1.99785910 |
| 127 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.98672475 |
| 128 | Acrocyanosis (HP:0001063) | 1.98467623 |
| 129 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98021175 |
| 130 | Parakeratosis (HP:0001036) | 1.97464681 |
| 131 | Acne (HP:0001061) | 1.96476616 |
| 132 | Poor head control (HP:0002421) | 1.95048433 |
| 133 | Esophageal varix (HP:0002040) | 1.93568774 |
| 134 | Epistaxis (HP:0000421) | 1.93103537 |
| 135 | Abnormality of the pericardium (HP:0001697) | 1.87260688 |
| 136 | Skin rash (HP:0000988) | 1.86536585 |
| 137 | Cheilitis (HP:0100825) | 1.86113130 |
| 138 | Recurrent pneumonia (HP:0006532) | 1.85227179 |
| 139 | Keratitis (HP:0000491) | 1.84717352 |
| 140 | Progressive neurologic deterioration (HP:0002344) | 1.83681156 |
| 141 | Panhypogammaglobulinemia (HP:0003139) | 1.82887991 |
| 142 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.81423027 |
| 143 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.81423027 |
| 144 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.81423027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.44114791 |
| 2 | MAP3K14 | 3.53792635 |
| 3 | MAP4K1 | 3.49987011 |
| 4 | IRAK4 | 3.16963308 |
| 5 | RIPK4 | 3.03454507 |
| 6 | ERN1 | 3.01879883 |
| 7 | TYK2 | 2.99555774 |
| 8 | CSK | 2.58140765 |
| 9 | IRAK3 | 2.47007439 |
| 10 | PRPF4B | 2.40989178 |
| 11 | TBK1 | 2.39146784 |
| 12 | CSF1R | 2.36737774 |
| 13 | FGFR4 | 2.17926925 |
| 14 | EPHB1 | 2.10835113 |
| 15 | TNK2 | 1.97150538 |
| 16 | MAP2K3 | 1.94951039 |
| 17 | MAP3K12 | 1.78020938 |
| 18 | FGR | 1.76321417 |
| 19 | IKBKB | 1.70330192 |
| 20 | MAP3K3 | 1.69870334 |
| 21 | TAOK3 | 1.64577268 |
| 22 | TRIB3 | 1.64323667 |
| 23 | BCKDK | 1.56533304 |
| 24 | NEK9 | 1.54123687 |
| 25 | TEC | 1.53237350 |
| 26 | JAK1 | 1.52610741 |
| 27 | KIT | 1.51846797 |
| 28 | GRK1 | 1.51788063 |
| 29 | BTK | 1.46929185 |
| 30 | STK10 | 1.45437366 |
| 31 | FLT3 | 1.44857795 |
| 32 | LRRK2 | 1.40981015 |
| 33 | KSR2 | 1.40725368 |
| 34 | ZAP70 | 1.38825631 |
| 35 | JAK3 | 1.35494031 |
| 36 | SYK | 1.34130266 |
| 37 | YES1 | 1.29620486 |
| 38 | MST1R | 1.26954047 |
| 39 | ITK | 1.26916918 |
| 40 | IKBKE | 1.25883497 |
| 41 | CDK19 | 1.23899497 |
| 42 | HCK | 1.21748939 |
| 43 | JAK2 | 1.18808794 |
| 44 | TGFBR2 | 1.13515723 |
| 45 | IRAK1 | 1.12552803 |
| 46 | FGFR3 | 1.12410706 |
| 47 | SIK3 | 1.12069151 |
| 48 | IRAK2 | 1.08251470 |
| 49 | EPHA3 | 1.05868461 |
| 50 | MAP3K2 | 1.04207782 |
| 51 | GRK6 | 1.03378904 |
| 52 | LYN | 1.00724524 |
| 53 | MATK | 0.95656108 |
| 54 | MAP3K13 | 0.94710944 |
| 55 | TRPM7 | 0.92118893 |
| 56 | TESK2 | 0.91250793 |
| 57 | TXK | 0.90243162 |
| 58 | CHUK | 0.89273383 |
| 59 | STK24 | 0.88959015 |
| 60 | KDR | 0.87737068 |
| 61 | NUAK1 | 0.84786898 |
| 62 | PDK1 | 0.81477454 |
| 63 | MAP3K11 | 0.81410117 |
| 64 | PIK3CG | 0.81271528 |
| 65 | MAP3K5 | 0.80962467 |
| 66 | MARK2 | 0.80930633 |
| 67 | RPS6KA4 | 0.80055803 |
| 68 | PIM1 | 0.78182186 |
| 69 | SIK1 | 0.73579191 |
| 70 | MYLK | 0.72830312 |
| 71 | CLK1 | 0.72802783 |
| 72 | MST4 | 0.72235428 |
| 73 | TTN | 0.70308252 |
| 74 | MAP2K6 | 0.70057598 |
| 75 | PDPK1 | 0.69611688 |
| 76 | PTK6 | 0.69159404 |
| 77 | MARK3 | 0.63951014 |
| 78 | FYN | 0.62918179 |
| 79 | ABL2 | 0.62652584 |
| 80 | MAPK7 | 0.60483311 |
| 81 | TAOK1 | 0.60266383 |
| 82 | LCK | 0.60230879 |
| 83 | CDC42BPA | 0.59658889 |
| 84 | FES | 0.59552839 |
| 85 | STK3 | 0.58652226 |
| 86 | NME2 | 0.57227461 |
| 87 | PRKAA2 | 0.56622469 |
| 88 | MAP2K4 | 0.56492501 |
| 89 | MAPK12 | 0.56001226 |
| 90 | PRKD2 | 0.54876572 |
| 91 | PTK2B | 0.54131000 |
| 92 | KSR1 | 0.53423391 |
| 93 | ABL1 | 0.52563933 |
| 94 | MAPKAPK2 | 0.51492247 |
| 95 | MOS | 0.51303693 |
| 96 | PRKCD | 0.50444558 |
| 97 | PKN2 | 0.49630851 |
| 98 | ERBB3 | 0.48923913 |
| 99 | BMPR2 | 0.48651587 |
| 100 | GRK7 | 0.48485039 |
| 101 | MAPK11 | 0.46732253 |
| 102 | FRK | 0.45776507 |
| 103 | RPS6KC1 | 0.45711124 |
| 104 | RPS6KL1 | 0.45711124 |
| 105 | MAP3K7 | 0.45527732 |
| 106 | EIF2AK2 | 0.45447226 |
| 107 | PRKG2 | 0.44792012 |
| 108 | SGK3 | 0.43046615 |
| 109 | STK4 | 0.42734785 |
| 110 | CAMK1D | 0.41868086 |
| 111 | MAPK4 | 0.41469851 |
| 112 | MAP3K1 | 0.41363313 |
| 113 | NLK | 0.41017987 |
| 114 | RAF1 | 0.40784443 |
| 115 | RET | 0.39572893 |
| 116 | PRKCQ | 0.38858163 |
| 117 | MAP2K2 | 0.38211648 |
| 118 | ACVR1B | 0.37659603 |
| 119 | SMG1 | 0.37427954 |
| 120 | TAOK2 | 0.37304801 |
| 121 | PTK2 | 0.36976602 |
| 122 | RPS6KA6 | 0.36170349 |
| 123 | SIK2 | 0.33810006 |
| 124 | EGFR | 0.31902824 |
| 125 | RIPK1 | 0.31420584 |
| 126 | DAPK2 | 0.31220720 |
| 127 | CAMKK2 | 0.30938001 |
| 128 | MAP3K6 | 0.27736691 |
| 129 | HIPK2 | 0.27642933 |
| 130 | STK11 | 0.27533157 |
| 131 | BMX | 0.27348616 |
| 132 | CDK6 | 0.26865172 |
| 133 | PAK4 | 0.26596351 |
| 134 | DYRK1B | 0.26572323 |
| 135 | MAP3K8 | 0.26164389 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.83751362 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.06693091 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.56361826 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.34986206 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.28075604 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.27509219 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.22728570 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.18737078 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.03939530 |
| 10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.01718391 |
| 11 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.00089627 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.95552493 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90814380 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87056405 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.86098440 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.84820446 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.81935567 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.79566431 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.77333544 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.74675742 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.67400794 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.60650922 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.53804849 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.51956799 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.49083539 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.46851946 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.46260705 |
| 28 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44189948 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.41930836 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.41576103 |
| 31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.38179893 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.37058053 |
| 33 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.33932219 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.33762162 |
| 35 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.30037555 |
| 36 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.28775590 |
| 37 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.27738352 |
| 38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.27469233 |
| 39 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.25242558 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 1.24457340 |
| 41 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.19170569 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.16866495 |
| 43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.16680209 |
| 44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.16630349 |
| 45 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.11682843 |
| 46 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.09184608 |
| 47 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.07032477 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.06698054 |
| 49 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.03014521 |
| 50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.02380427 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.02238181 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 1.00909499 |
| 53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.00155487 |
| 54 | Lysosome_Homo sapiens_hsa04142 | 0.99447006 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.98485677 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97909882 |
| 57 | Salmonella infection_Homo sapiens_hsa05132 | 0.96553527 |
| 58 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.96131320 |
| 59 | Malaria_Homo sapiens_hsa05144 | 0.94546922 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.93446985 |
| 61 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.91031978 |
| 62 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.89247863 |
| 63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.87027781 |
| 64 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.85915044 |
| 65 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.84890748 |
| 66 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.84731969 |
| 67 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.84197038 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.82675706 |
| 69 | Influenza A_Homo sapiens_hsa05164 | 0.81937938 |
| 70 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.81189177 |
| 71 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.80750414 |
| 72 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79768058 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79283917 |
| 74 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.77377113 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76184332 |
| 76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.74184685 |
| 77 | Shigellosis_Homo sapiens_hsa05131 | 0.74103237 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73776877 |
| 79 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.73049320 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72797840 |
| 81 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.72539911 |
| 82 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71465966 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.70672524 |
| 84 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.70533559 |
| 85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70513740 |
| 86 | Measles_Homo sapiens_hsa05162 | 0.69827215 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69499396 |
| 88 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69286779 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68686259 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68139943 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.67809321 |
| 92 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67188665 |
| 93 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66604894 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.66331873 |
| 95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65998845 |
| 96 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.65417359 |
| 97 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64340378 |
| 98 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.63573385 |
| 99 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59596800 |
| 100 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.59558234 |
| 101 | Phagosome_Homo sapiens_hsa04145 | 0.56266776 |
| 102 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55774042 |
| 103 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55313247 |
| 104 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55255264 |
| 105 | Allograft rejection_Homo sapiens_hsa05330 | 0.55231604 |
| 106 | Bile secretion_Homo sapiens_hsa04976 | 0.54257675 |
| 107 | Apoptosis_Homo sapiens_hsa04210 | 0.54064664 |
| 108 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54032946 |
| 109 | Hepatitis C_Homo sapiens_hsa05160 | 0.53984529 |
| 110 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.53571459 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52841900 |
| 112 | Viral myocarditis_Homo sapiens_hsa05416 | 0.52804558 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52249436 |
| 114 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.51661541 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50771047 |
| 116 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50296043 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | 0.50137852 |
| 118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49490874 |
| 119 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49321426 |
| 120 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.48618524 |
| 121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48247511 |
| 122 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48059421 |
| 123 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.46348166 |
| 124 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45919624 |
| 125 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45003848 |
| 126 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.44958766 |
| 127 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.44222153 |
| 128 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43841899 |
| 129 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.41343858 |
| 130 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41168901 |
| 131 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40860276 |
| 132 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40454964 |
| 133 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40022821 |
| 134 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39559232 |
| 135 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39506714 |
| 136 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.38389476 |
| 137 | Asthma_Homo sapiens_hsa05310 | 0.37714834 |
| 138 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.36682126 |
| 139 | Platelet activation_Homo sapiens_hsa04611 | 0.35974676 |
| 140 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35404047 |
| 141 | Bladder cancer_Homo sapiens_hsa05219 | 0.34107999 |
| 142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33995326 |
| 143 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32072117 |
| 144 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.31552496 |
| 145 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.30104662 |
| 146 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28357427 |
| 147 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.27645285 |

